Small interfering RNA-mediated silencing of nicotinamide phosphoribosyltransferase induce growth inhibition and apoptosis in human multiple myeloma cells: a preliminary study

Multiple myeloma (MM) is a malignancy of B lymphocytes or plasma cells. Our array-based comparative genomic hybridization findings revealed chromosomal gains at 7q22.3 and 1q42.3, where nicotinamide (NAM) phosphoribosyltransferase (NAMPT) and lysosomal trafficking regulator (LYST) genes are localize...

Full description

Saved in:
Bibliographic Details
Published in:Bosnian journal of basic medical sciences 2016-11, p.268
Main Authors: Bong, Ivyna Pau Ni, Ng, Ching Ching, Fakiruddin, Shaik Kamal, Lim, Moon Nian, Zakaria, Zubaidah
Format: Article
Language:English
Subjects:
Apoptosis
B cells
Cancer
Comparative analysis
Cytogenetics
DNA polymerases
Enzyme-linked immunosorbent assay
Enzymes
Fluorescein
Genes
Genetic aspects
Genetic engineering
Multiple myeloma
Niacinamide
Purines
RNA
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Multiple myeloma (MM) is a malignancy of B lymphocytes or plasma cells. Our array-based comparative genomic hybridization findings revealed chromosomal gains at 7q22.3 and 1q42.3, where nicotinamide (NAM) phosphoribosyltransferase (NAMPT) and lysosomal trafficking regulator (LYST) genes are localized, respectively. This led us to further study the functions of these genes in myeloma cells. NAMPT is a key enzyme involved in nicotinamide adenine dinucleotide salvage pathway, and it is frequently overexpressed in human cancers. In contrast, little is known about the function of LYST in cancer. The expression of LYST is shown to affect lysosomal size, granule size, and autophagy in human cells. In this study, the effects of small interfering RNA (siRNA)-mediated silencing of NAMPT and LYST on cell proliferation and apoptosis were evaluated in RPMI 8226 myeloma cells. Transfection efficiencies were determined by quantitative real time reverse transcriptase PCR. Cell proliferation was determined using MTT assay, while apoptosis was analyzed with flow cytometry using Annexin V-fluorescein isothiocyanate/propidium iodide assay. The NAMPT protein expression in siRNA-treated cells was estimated by enzyme-linked immunosorbent assay. Our results showed that NAMPT and LYST were successfully knockdown by siRNA transfection (p < 0.05). NAMPT or LYST gene silencing significantly inhibited cell proliferation and induced apoptosis in RPMI 8226 cells (p < 0.05). Silencing of NAMPT gene also decreased NAMPT protein levels (p < 0.01). Our study demonstrated that NAMPTand LYST play pivotal roles in the molecular pathogenesis of MM. This is the first report describing the possible functions of LYST in myelomagenesis and its potential role as a therapeutic target in MM. KEY WORDS: Multiple myeloma; nicotinamide phosphoribosyltransferase; lysosomal trafficking regulator; small interfering RNA; cell proliferation; apoptosis DOI:
ISSN:1512-8601
DOI:10.17305/bjbms.2016.1568